The National Institutes of Allergy and Infectious Diseases (NIAID), NIH, intends to negotiate with the Emory University for a modification of its contract No. N01-AI-25456, which was awarded as a sole source acquisition under Authority 41 U.S.C. 253 (c)(1), and FAR 6.302-1(b)(1), to increase the production of Class II MHC tetramers, as well as the creation of new classes of tetramers for the expected increase in bio-defense-related research. A more rapid turnaround time and increased batch capacity will help facilitate the growing number of mechanistic studies associated with vaccine trials. Authority: 41 USC 253 (c)(1), as set forth in FAR 6.302-1(b)(1), Only one responsible source. See Government-wide Numbered Note 22. No collect calls will be accepted.

Bid Protests Not Available